Senior Editor, Diagnostic Imaging
Can an Emerging PSMA/PET Agent Improve Detection of Prostate Cancer Recurrence in Patients with Low PSAs?May 1st 2023
In a recent video interview from the American Urological Association (AUA) 2023 Annual Meeting, Brian Helfand, M.D., discussed emerging research that shows the potential viability of the agent F18-rhPSMA-7.3 for enhancing the detection of prostate cancer recurrence and facilitating earlier intervention for patients with low prostate-specific antigen (PSA) levels.
FDA Clears RadNet's Updated AI Software for Prostate MRIMay 1st 2023
An update to Quantib Prostate 2.1, Quantib Prostate 3.0 reportedly facilitates workflow advances and offers a variety of tools, ranging from artificial intelligence (AI)-based segmentation to PI-RADS scoring support, to help improve interpretation of prostate magnetic resonance imaging (MRI).
CT Update: FDA Changes Course on Post-ICM Thyroid Monitoring in Young ChildrenApril 28th 2023
Revising a March 2022 recommendation, the Food and Drug Administration (FDA) said thyroid monitoring for young children three years of age and under receiving iodinated contrast media (ICM) in relation to contrast-enhanced computed tomography (CECT) can now be reserved for those with risk factors including prematurity, low birth weight or conditions affecting thyroid function.
TeraRecon Launches AI-Powered Neuro SuiteApril 28th 2023
The artificial intelligence (AI)-powered Neuro Suite reportedly enables radiologists to access leading neurological AI algorithm solutions in the field, including the brain magnetic resonance imaging (MRI) segmentation capabilities of the Combinostics’ algorithm that can help differentiate degenerative pathologies such as Alzheimer’s disease and dementia.
Microvascular Invasion in Hepatocellular Carcinoma: Can a CT Radiomics Model Have an Impact?April 27th 2023
A hybrid computed tomography radiomics model demonstrated up to an 86 percent area under the curve in predicting microvascular invasion in patients with hepatocellular carcinoma in a recently published study.
Study Shows Benefits of Reduced Energy Consumption with MRI Devices and Possible Millions in Cost SavingsApril 26th 2023
Researchers suggested that overnight use of a power-save mode on outpatient magnetic resonance imaging (MRI) devices in the United States could reduce annual energy consumption by 76,288.2 megawatt hours (MWh) and add up to $10.7 million in cost savings.
New Study Assesses Cancer Risks with CT in Pediatric PatientsApril 24th 2023
While one computed tomography (CT) scan appears to have no elevated cancer risk in pediatric patients, four or more pediatric exposures to CT scans are associated with increased risks for intracranial tumor, leukemia, and non-Hodgkin lymphoma, according to newly published research out of Taiwan.
Emerging AI Tool Improves Worklist Triage and CT Detection of Incidental Pulmonary EmbolismApril 21st 2023
In a new study involving over 11,700 chest computed tomography (CT) scans in oncology patients, adjunctive artificial intelligence software demonstrated a sensitivity rate of 91.6 percent for incidental pulmonary embolism (IPE) and reduced median detection and notification time for IPE-positive scans from multiple days to one hour for a radiology department at a comprehensive cancer center.
Spine Radiology Insights on Venous Fistula Localization and Finding Cerebrospinal Fluid LeaksApril 19th 2023
In a recent lecture at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting, Andrew Callen, M.D., discussed a variety of imaging features associated with cerebrospinal fluid (CSF) leaks, the diagnostic utility of the Bern score as well as the merits of 3D T2FS MRI and dynamic computed tomography myelography.
Does Timing of Imaging Affect Interpretation of Contrast-Enhanced Mammography?April 19th 2023
Earlier initiation of imaging after contrast administration with contrast-enhanced mammography may provide better visibility of lesions and conspicuity against background parenchymal enhancement, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
RapidAI Gets FDA Nod for AI Assessment of Non-Contrast CT for Acute Stroke TriageApril 18th 2023
Powered by artificial intelligence (AI), the Rapid NCCT Stroke modality is reportedly the first medical device to gain FDA 510(k) clearance for detecting suspected large vessel occlusion and intracranial hemorrhage based on assessment of non-contrast computed tomography (NCCT).
Breast Reconstruction: Current Principles and Emerging Concepts in ImagingApril 17th 2023
Given the increasing prevalence of breast reconstruction, researchers discussed key signs of common complications on magnetic resonance imaging (MRI), ultrasound and other imaging during a recent presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Award-Winning Study Shows Benefits of 3D MRI for Assessing the Fetal Optic PathwayApril 16th 2023
Three-dimensional (3D) slice-to-volume (SVR) fetal magnetic resonance imaging (MRI) has over six times the fetal optic pathway visualization rate of standard two-dimensional MRI, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Is There More Appropriate Use of BI-RADS Category 3 with DBT than Mammography in Patients with Breast Cancer History?April 14th 2023
Recent research involving nearly 15,000 mammography exams in patients with a personal history of breast cancer revealed that digital breast tomosynthesis (DBT) was associated with a lower frequency of BI-RADS category 3 assessment and a lower malignancy rate for BI-RADS 3 lesions in comparison to full-field digital mammography.
What a Ten-Year CT Study Reveals About Emphysema and Continued SmokingApril 13th 2023
Over the course of a decade, people with preexisting emphysema who continued smoking had the greatest decline in lung density, according to computed tomography (CT) findings from a study involving over 8,400 total participants and over 4,100 current smokers.
Emerging Prostate and Brain MRI AI Platform Gets FDA NodApril 13th 2023
In addition to a previously FDA-cleared brain magnetic resonance imaging (MRI) module, the Advantis Platform features an artificial intelligence-powered prostate MRI module that offers simultaneous viewing of conventional and advanced sequences, and reportedly generates automated PI-RADS assessments.
Can Explainable AI Enhance Diagnosis and PI-RADS Classification of Prostate Cancer on MRI?April 12th 2023
In a study of over 1,200 men with over 3,200 prostatic lesions, an explainable artificial intelligence (AI) model demonstrated a sensitivity rate of 93 percent for detecting clinically significant prostate cancer.
BD Launches Ultrasound Guidance Modality to Facilitate Optimal IV AccessApril 11th 2023
The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.
AI-Based Denoising Technique Achieves 76 Percent Reduction in Radiation Dosing for CT Lung Cancer ScreeningApril 11th 2023
New prospective research demonstrated that the combination of ultra-low-dose (ULD) computed tomography (CT) and an artificial intelligence (AI)-based denoising method offered a greater than 95 percent sensitivity rate for differentiating negative and actionable Lung-RADS category findings with significantly reduced radiation dosing.
Is PET/CT Better than CT for Monitoring Metastatic Breast Cancer Treatment?April 10th 2023
A recent prospective study found that progression-free survival (PFS) and disease-specific survival (DSS) were significantly associated with breast cancer tumor treatment response on 2-(18F)FDG-PET/CT imaging in comparison to contrast-enhanced computed tomography (CT), which showed no evidence of a significant association with tumor response.
Can AI Improve Triage of CT Pulmonary Angiography Exams for Acute PE?April 7th 2023
A recent study showed that artificial intelligence (AI)-based worklist reprioritization led to a mean reduction of 12.3 minutes in radiology report turnaround time for positive computed tomography pulmonary angiography (CTPA) exams that were positive for pulmonary embolism.
Study Looks at Contributing Factors to Incomplete Follow-Up for BI-RADS 3 FindingsApril 6th 2023
Emerging research suggests that 29 percent of patients with index breast magnetic resonance imaging (MRI) exams, 45 percent of Asian women and 30 percent of women living in the highest disadvantaged neighborhoods did not have follow-up imaging after a BI-RADS 3 diagnosis.
Study Finds AI More Effective Than Sonographer Interpretation of Cardiac Function on EchocardiogramsApril 5th 2023
Based on a review of 3,495 echocardiographic studies to evaluate left ventricular ejection fraction (LVEF), researchers found that cardiologists changed initial artificial intelligence (AI) assessment 16.8 percent of the time and initial sonographer assessment 27.2 percent of the time.
Can ChatGPT Provide Appropriate Information on Mammography and Other Breast Cancer Screening Topics?April 5th 2023
Researchers found that ChatGPT offered appropriate responses to 22 out of 25 patient-oriented questions on mammography screening, dense breasts, BI-RADS scoring and other topics related to breast cancer screening and prevention.
New Medtronic App Streamlines MRI Screening for Patients with Cardiac DevicesApril 5th 2023
Offering built-in safety features and independent verification of magnetic resonance imaging (MRI) compatibility with cardiac devices such as pacemakers or implantable cardioverter defibrillator systems, the MRI Care Pathway app may enhance the efficiency of radiology workflows for MRI scans in patients with these devices.